Profile data is unavailable for this security.
About the company
INIFY Laboratories AB is a Sweden-based medical research company that provides cancer diagnostics through laboratory services within pathology. The Company uses a fully digital, standardized and Artificial Intelligence (AI)- supported workflow to optimize quality and response times, initially within prostate. The service includes the whole chain of sample handling: from logistics, to sample preparation, to reporting by a pathologist from either Inify Laboratories or the customer’s organization. INIFY Laboratories' laboratory in Solna, Sweden is intended to provide two types of analyses of prostate Biopsy Specimens to clients: Full pathology Report signed by an INIFY subspecialized pathologist and Whole Slide Images (WSI) generation and result of Pathology Decision Support Tool (PDST) analysis only. The Company origins from ContextVision.
- Revenue in NOK (TTM)3.52m
- Net income in NOK-52.91m
- Incorporated2021
- Employees23.00
- LocationINIFY Laboratories ABScheeles vag 3SOLNA 171 65SwedenSWE
- Phone+46 8267330
- Websitehttps://www.inify.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Neola Medical AB | 0.00 | -9.73m | 201.86m | 7.00 | -- | 2.66 | -- | -- | -0.1508 | -0.1508 | 0.00 | 1.05 | 0.00 | -- | -- | 0.00 | -12.63 | -17.04 | -13.59 | -18.46 | -- | 4,237.20 | -- | -5,258.78 | -- | -- | 0.00 | -- | -- | -- | 12.97 | -- | 55.46 | -- |
SpectraCure AB (publ) | 2.43m | -21.76m | 203.13m | 13.00 | -- | 1.68 | -- | 83.61 | -0.218 | -0.218 | 0.0243 | 1.21 | 0.0166 | -- | 24.63 | 157,600.00 | -14.82 | -12.75 | -15.91 | -13.62 | 442.39 | 195.30 | -895.85 | -494.40 | -- | -- | 0.0494 | -- | -3.30 | -- | 19.46 | -- | -- | -- |
Bactiquant A/S | 14.07m | -22.69m | 215.31m | -- | -- | 20.13 | -- | 15.30 | -0.6558 | -0.6558 | 0.4064 | 0.2906 | 0.5101 | 2.94 | 5.06 | -- | -82.23 | -41.26 | -92.65 | -47.16 | -24.34 | 12.89 | -161.20 | -71.77 | 2.73 | -9.48 | 0.5326 | -- | -0.689 | -- | 7.62 | -- | -- | -- |
Nanexa AB | 27.65m | -68.53m | 221.73m | 19.00 | -- | 2.48 | -- | 8.02 | -0.6938 | -0.6938 | 0.2484 | 0.6411 | 0.2108 | -3.83 | 2.99 | 1,416,316.00 | -52.24 | -40.77 | -70.59 | -48.77 | 118.77 | 77.27 | -247.79 | -532.26 | 1.92 | -- | 0.0174 | -- | 925.42 | 147.00 | -30.44 | -- | 39.10 | -- |
Scandinavian Medical Solutions A/S | 309.38m | 8.41m | 267.08m | 25.00 | 31.58 | 2.21 | 14.07 | 0.8633 | 0.1963 | 0.1963 | 7.22 | 2.81 | 1.38 | 1.89 | 11.35 | -- | 3.75 | -- | 6.15 | -- | 24.48 | -- | 2.72 | -- | 0.4307 | 5.54 | 0.3473 | -- | 72.98 | -- | 7.49 | -- | -- | -- |
Micropos Medical AB (publ) | 2.76m | -23.31m | 272.91m | 9.00 | -- | 12.98 | -- | 99.06 | -0.2463 | -0.2463 | 0.022 | 0.1341 | 0.0994 | 0.1315 | 1.20 | 335,122.50 | -84.10 | -64.24 | -111.33 | -82.27 | 79.96 | 114.76 | -845.91 | -767.57 | 3.18 | -- | 0.0184 | -- | 50.23 | 5.94 | -26.57 | -- | -- | -- |
Acarix AB | 6.43m | -72.91m | 293.03m | 9.00 | -- | 4.21 | -- | 45.57 | -0.1168 | -0.1168 | 0.0095 | 0.0697 | 0.0894 | 0.1172 | 2.47 | -- | -101.38 | -66.93 | -123.43 | -77.12 | 88.27 | 79.42 | -1,133.87 | -1,483.68 | 5.21 | -328.98 | 0.00 | -- | 7.20 | 43.55 | -1.11 | -- | -- | -- |
Karolinska Development AB | 1.96m | -5.81m | 326.06m | 8.00 | -- | 0.26 | -- | 166.73 | -0.0209 | -0.0209 | 0.007 | 4.56 | 0.0015 | -- | 1.38 | 237,875.00 | -0.4536 | 3.37 | -0.4578 | 3.83 | -- | -- | -296.85 | 1,466.36 | -- | -- | 0.0021 | 0.00 | -12.43 | -8.10 | 106.11 | -29.31 | -- | -- |
Ortoma AB | 44.41m | -31.63m | 326.87m | 7.00 | -- | 1.92 | -- | 7.36 | -0.8112 | -0.8112 | 1.24 | 4.67 | 0.2294 | 1.01 | 4.49 | 6,173,962.00 | -16.34 | -10.45 | -17.53 | -11.64 | 86.83 | 339.86 | -71.22 | -175.52 | 3.04 | -- | 0.00 | -- | -- | -- | -38.87 | -- | 14.14 | -- |
Q linea AB | 4.82m | -230.82m | 334.13m | 99.00 | -- | 4.77 | -- | 69.25 | -2.06 | -2.06 | 0.0428 | 0.5813 | 0.0277 | 0.1707 | 11.86 | 36,968.50 | -132.70 | -59.66 | -356.93 | -66.14 | -56.25 | -378.58 | -4,783.96 | -4,046.97 | 0.6999 | -- | 0.4555 | -- | -65.28 | 33.02 | 14.64 | -- | 41.94 | -- |
Nexstim Oyj | 92.49m | -9.73m | 334.23m | 39.00 | -- | 15.32 | -- | 3.61 | -0.1223 | -0.1223 | 1.19 | 0.2761 | 0.8196 | 0.2223 | 5.28 | 214,040.30 | -8.62 | -26.77 | -14.02 | -43.90 | 97.24 | 92.11 | -10.52 | -38.38 | 1.24 | -5.51 | 0.7716 | -- | -23.94 | 22.08 | -201.58 | -- | 19.51 | -- |
Boule Diagnostics AB | 588.37m | 21.87m | 339.21m | 230.00 | 15.83 | 0.6652 | 6.96 | 0.5765 | 0.5368 | 0.5368 | 14.45 | 12.78 | 0.724 | 4.19 | 3.69 | 2,511,092.00 | 2.68 | 1.67 | 3.71 | 2.40 | 43.86 | 43.50 | 3.70 | 2.04 | 0.9268 | 4.72 | 0.2698 | 42.24 | 4.24 | 6.13 | 96.24 | -9.45 | -9.74 | -- |
INIFY Laboratories AB | 3.52m | -52.91m | 360.64m | 23.00 | -- | 4.79 | -- | 102.45 | -1.17 | -1.17 | 0.0778 | 1.66 | 0.032 | 2.99 | 0.6608 | -- | -48.10 | -- | -48.10 | -- | 76.42 | -- | -1,503.10 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
ContextVision AB | 136.19m | 26.43m | 408.10m | 41.00 | 15.44 | 4.41 | 11.52 | 3.00 | 0.3416 | 0.3416 | 1.76 | 1.19 | 1.21 | 2.33 | 4.81 | 3,404,739.00 | 23.39 | 29.39 | 30.67 | 43.27 | 97.39 | 98.58 | 19.40 | 27.15 | 3.99 | -- | 0.0304 | -- | 12.19 | 7.78 | -1.77 | -- | -35.88 | -- |
BrainCool AB (publ) | 33.12m | -58.75m | 474.45m | 20.00 | -- | 2.79 | -- | 14.32 | -0.2685 | -0.2685 | 0.1501 | 0.6527 | 0.2253 | 2.04 | 2.85 | 1,343,042.00 | -39.96 | -47.14 | -44.79 | -70.16 | -37.24 | -149.77 | -177.38 | -391.45 | 4.16 | -6.19 | 0.00 | -- | 32.06 | 78.35 | -34.34 | -- | -11.63 | -- |
Integrum AB | 105.01m | -2.59m | 522.37m | 36.00 | -- | 2.83 | 670.66 | 4.97 | -0.1244 | -0.1244 | 5.29 | 9.58 | 0.5706 | 0.5666 | 3.59 | 2,620,068.00 | -1.41 | -1.71 | -1.55 | -1.98 | 87.25 | 83.87 | -2.47 | -2.87 | 5.54 | -0.6636 | 0.0325 | -- | 40.19 | 35.91 | 124.92 | -- | 127.10 | -- |
Holder | Shares | % Held |
---|---|---|
Danske Bank A/S (Investment Management Sweden)as of 01 Feb 2024 | 2.05m | 4.53% |
MP Pensjon PKas of 01 Feb 2024 | 1.37m | 3.03% |
SEB Investment Management ABas of 01 Feb 2024 | 185.44k | 0.41% |
Aktia Bank Plc (Investment Management)as of 31 Jul 2024 | 172.70k | 0.38% |